TCB-008

DB18352Investigational

TCB-008 is an Allogeneic CD3+ T lymphocyte ex vivo expanded expressing the gamma delta T-cell receptor.

Code names
TCB-008

Resolves to

Compound
UNIIGBR4N4S63E

What you can answer from here — as of September 21, 2023

3Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of TCB-008, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In